Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG CLASS:

CLDN6-targeted CAR-T immunotherapy

DRUG CLASS:

CLDN6-targeted CAR-T immunotherapy

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Related drugs:

‹

›

Testicular Cancer

Sensitive: B - Late Trials

Sensitive: B - Late Trials